4-methoxyamphetamine has been researched along with paclitaxel in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, SG; Cloonan, SM; Corrigan, D; Jørgensen, AM; Keating, JJ; Knox, AJ; Lloyd, DG; Meegan, MJ; Peters, GH; Rai, D; Williams, DC | 1 |
| Bocksch, W; Boxberger, M; Degenhardt, R; Gross, M; Horstkotte, D; Nienaber, C; Schneider, H; Unverdorben, M; Vallbracht, C; Wiemer, M | 1 |
| Cutlip, DE; Kint, PP; Morel, MA; Serruys, PW; Van Es, GA; Vranckx, P | 1 |
| Aharonian, VJ; Brar, SK; Brar, SS; Dangas, G; Gray, WA; Leon, MB; Moses, JW | 1 |
| Fahy, M; Kedhi, E; Kereiakes, DJ; Parise, H; Serruys, PW; Smits, PC; Stone, GW | 1 |
| Fujii, K; Hirayama, H; Iwabuchi, M; Kotani, J; Kozuma, K; Muramatsu, T; Nakamura, M; Saito, S; Uchida, T | 1 |
| Airaksinen, KE; Karjalainen, PP; Kervinen, K; Nammas, W; Niemelä, M; Nyman, K; Pietilä, M; Sia, J; Tuomainen, PO; Ylitalo, A | 2 |
| Antoniucci, D; Carrabba, N; Dovellini, EV; Migliorini, A; Parodi, G; Valenti, R; Vergara, R | 1 |
| Kotani, J; Kozuma, K; Nakamura, M; Okura, H | 1 |
| Dias, S; Petrou, P | 1 |
| Hu, W; Li, L; Song, M | 1 |
| Kikuchi, M; Mano, N; Obara, T; Tsuchiya, M | 1 |
3 review(s) available for 4-methoxyamphetamine and paclitaxel
| Article | Year |
|---|---|
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials.
Topics: Coronary Angiography; Death; Drug-Eluting Stents; Equipment Design; Humans; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Patient Selection; Randomized Controlled Trials as Topic; Recurrence; Risk; Sirolimus; Thrombosis; Treatment Outcome | 2009 |
A mixed treatment comparison for short- and long-term outcomes of bare-metal and drug-eluting coronary stents.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Death; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2016 |
Grading Evaluation of Cardiotoxicity in Patients with Breast Cancer Treated with Adjuvant Paclitaxel Anthracycline/Cyclophosphamide Chemotherapy: A Meta-Analysis.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotoxicity; Cyclophosphamide; Death; Female; Heart Failure; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Receptor, ErbB-2 | 2022 |
6 trial(s) available for 4-methoxyamphetamine and paclitaxel
| Article | Year |
|---|---|
The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I) : the one-year clinical follow-up.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Survival Rate; Thrombosis; Ticlopidine; Tubulin Modulators | 2007 |
Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Death; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Proportional Hazards Models; Prospective Studies; Single-Blind Method; Sirolimus | 2011 |
Effectiveness of paclitaxel-eluting stents in complex clinical patients. -Insights from the TAXUS Japan Postmarket surveillance study.-.
Topics: Aged; Angioplasty; Antineoplastic Agents, Phytogenic; Death; Diabetes Complications; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prevalence; Product Surveillance, Postmarketing; Renal Dialysis; Retrospective Studies; Risk Factors | 2011 |
Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Paclitaxel; Recurrence; Retrospective Studies; Sex Characteristics; Stents; Titanium; Treatment Outcome | 2012 |
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
Topics: Aged; Cohort Studies; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Time Factors; Titanium; Treatment Outcome | 2013 |
gender-specific outcome after paclitaxel-eluting stent implantation in japanese patients with coronary artery disease--sub-analysis of the Japan TAXUS Express2 post-marketing survey.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Asian People; Death; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Registries; Sex Characteristics; Sex Factors; Time Factors | 2013 |
4 other study(ies) available for 4-methoxyamphetamine and paclitaxel
| Article | Year |
|---|---|
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
Topics: Amphetamines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Phenethylamines; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Sulfur | 2009 |
Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water.
Topics: Blood Platelets; Consensus; Coronary Thrombosis; Death; Drug-Eluting Stents; Humans; Incidence; Myocardial Infarction; Paclitaxel; Research Design; Thrombectomy | 2008 |
Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Death; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Registries; Sirolimus; Treatment Outcome | 2012 |
The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Death; Humans; Japan; Paclitaxel; Prevalence; Quality of Life | 2023 |